LabGenomics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	89,364	85,898	71,076	144,573	202,289	119,369
Other Revenue	-0	-0	-	199.59	117.98	109.43
Revenue	89,364	85,898	71,076	144,773	202,407	119,478
Revenue Growth (YoY)	6.71%	20.85%	-50.91%	-28.48%	69.41%	260.14%
Cost of Revenue	57,998	55,714	41,578	48,652	77,521	48,159
Gross Profit	31,366	30,184	29,499	96,121	124,886	71,319
Selling, General & Admin	37,658	38,374	28,636	25,996	18,518	14,686
Research & Development	2,158	2,681	2,624	1,865	556.87	-
Amortization of Goodwill & Intangibles	3,745	3,274	1,324	77.07	63.39	70.16
Other Operating Expenses	730.73	659.23	634.68	591.29	361.38	332.68
Operating Expenses	65,025	48,675	36,422	29,915	20,368	16,413
Operating Income	-33,659	-18,491	-6,923	66,206	104,518	54,906
Interest Expense	-5,501	-5,508	-4,953	-573.97	-208.03	-223.8
Interest & Investment Income	960.64	2,160	4,546	1,111	154.71	111.28
Earnings From Equity Investments	-173.1	-636.06	-1,969	-72.11	-46.37	-22.1
Currency Exchange Gain (Loss)	68.67	67.53	1,215	1,145	2,146	-1,171
Other Non Operating Income (Expenses)	5,116	1,721	-1,474	-448.52	90.13	128.96
EBT Excluding Unusual Items	-33,188	-20,686	-9,557	67,367	106,655	53,729
Gain (Loss) on Sale of Investments	350.24	4,278	1,016	-3,929	2,531	-268.91
Gain (Loss) on Sale of Assets	-150.41	-72.83	1,409	-44.62	0.9	-
Asset Writedown	-9,471	-9,471	-	-	-55.2	-1,636
Other Unusual Items	-	-	-	-	-	-1.75
Pretax Income	-42,459	-25,952	-7,133	63,393	109,132	51,822
Income Tax Expense	-6,648	-2,260	-1,842	15,467	25,277	9,058
Earnings From Continuing Operations	-35,812	-23,691	-5,291	47,926	83,855	42,764
Earnings From Discontinued Operations	-	-212.79	44.98	-	-	-
Net Income to Company	-35,812	-23,904	-5,246	47,926	83,855	42,764
Minority Interest in Earnings	-0	108.11	571.89	471.27	-	2.91
Net Income	-35,812	-23,796	-4,674	48,397	83,855	42,766
Net Income to Common	-35,812	-23,796	-4,674	48,397	83,855	42,766
Net Income Growth	-	-	-	-42.29%	96.08%	4343.63%
Shares Outstanding (Basic)	74	74	74	68	68	66
Shares Outstanding (Diluted)	74	74	74	68	68	66
Shares Change (YoY)	-0.39%	-	9.63%	0.20%	2.61%	6.06%
EPS (Basic)	-482.38	-320.53	-62.96	714.67	1240.72	649.30
EPS (Diluted)	-482.38	-320.53	-62.96	714.50	1240.50	649.30
EPS Growth	-	-	-	-42.40%	91.05%	4089.83%
Free Cash Flow	-28,439	-16,663	-8,817	31,307	51,645	45,673
Free Cash Flow Per Share	-383.07	-224.45	-118.76	462.30	764.15	693.42
Gross Margin	35.10%	35.14%	41.50%	66.39%	61.70%	59.69%
Operating Margin	-37.66%	-21.53%	-9.74%	45.73%	51.64%	45.95%
Profit Margin	-40.07%	-27.70%	-6.58%	33.43%	41.43%	35.79%
Free Cash Flow Margin	-31.82%	-19.40%	-12.40%	21.63%	25.52%	38.23%
EBITDA	-23,099	-8,891	-1,027	70,171	107,858	58,333
EBITDA Margin	-25.85%	-10.35%	-1.44%	48.47%	53.29%	48.82%
D&A For EBITDA	10,560	9,599	5,896	3,965	3,340	3,427
EBIT	-33,659	-18,491	-6,923	66,206	104,518	54,906
EBIT Margin	-37.66%	-21.53%	-9.74%	45.73%	51.64%	45.95%
Effective Tax Rate	-	-	-	24.40%	23.16%	17.48%
Advertising Expenses	-	194.43	58.85	100.91	74.86	31.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.